Asia-Pacific Medical Membrane Market Research Report – Segmentation by Technology (Reverse Osmosis, Microfiltration, Ultrafiltration, Nanofiltration, Ion Exchange, Others), Application (Environmental, Food and Beverages, Healthcare, Pharmaceutical, Others), and Material [Polyethersulfone (PES), Polysulfone (PSF), Polypropylene (PP), Polyvinylidene Fluoride (PVDF), Polyacrylonitrile (PAN), Others); and Region - Size, Share, Growth Analysis | Forecast (2024 – 2030)
Published: 2024 - January
Report Code: IM-15339
Format:
Region: Asia Pacific
Chapter 1. Asia-Pacific Medical Membrane Market – Scope & Methodology
1.1. Market Segmentation
1.2. Assumptions
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. Asia-Pacific Medical Membrane Market – Executive Summary
2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.3. COVID-19 Impact Analysis
2.3.1. Impact during 2023 – 2030
2.3.2. Impact on Supply – Demand
Chapter 3. Asia-Pacific Medical Membrane Market – Competition Scenario
3.1. Market Share Analysis
3.2. Product Benchmarking
3.3. Competitive Strategy & Development Scenario
3.4. Competitive Pricing Analysis
3.5. Supplier - Distributor Analysis
Chapter 4. Asia-Pacific Medical Membrane Market - Entry Scenario
4.1. Case Studies – Start-up/Thriving Companies
4.2. Regulatory Scenario - By Region
4.3 Customer Analysis
4.4. Porter's Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. Asia-Pacific Medical Membrane Market - Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6. Asia-Pacific Medical Membrane Market - By Technology
6.1 Reverse Osmosis
6.2. Microfiltration
6.3. Ultrafiltration
6.4. Nanofiltration
6.5. Ion Exchange
6.6. Others
Chapter 7. Asia-Pacific Medical Membrane Market - By Application
7.1. Environmental
7.2. Food and Beverages
7.3. Healthcare
7.4. Pharmaceutical
7.5. Others
Chapter 8. Asia-Pacific Medical Membrane Market - By Material
8.1. Polyethersulfone (PES)
8.2. Polysulfone (PSF)
8.3. Polypropylene (PP)
8.4. Polyvinylidene Fluoride (PVDF)
8.5. Polyacrylonitrile (PAN)
8.6. Others
Chapter 9. Asia-Pacific Medical Membrane Market – By Region
9.1. China
9.2. Japan
9.3. India
9.4. South Korea
9.5. Australia
9.6. Bangladesh
9.7. Sri Lanka
9.8. Southeast Asia
Chapter 10. Asia-Pacific Medical Membrane Market – Company Profiles – (Overview, Product Portfolio, Financials, Developments)
10.1. 3M
10.2. Alfa Laval AB
10.3. DuPont de Nemours Inc
10.4. GEA Group AG
10.5. Hydranautics
10.6. Koch Separation Systems Inc
10.7. MANN+HUMMEL International GmbH & Co KG
10.8. Pentair Plc
10.9. ProMinent GmbH
10.10. Veolia Water Technologies SASU
Download Sample
Choose License Type
2500
3400
3900
4600
Frequently Asked Questions
The Asia-Pacific Medical Membrane Market was estimated to be worth USD 88.56 Million in 2022 and is projected to reach a value of USD 185.73 Million by 2030, growing at a CAGR of 9.7% during the forecast period 2023-2030.
Medical uses of membrane technology are crucial, particularly for a variety of life-saving treatments. Drug delivery, tissue regeneration, artificial organs, and diagnostic tools including medical device coatings and bio-separations are some of its main medical uses.
High-Performance Nanostructured Material Development and the increase in illness incidence in the world are the drivers of the Asia-Pacific Medical Membrane Market.
A drawback for the Asia-Pacific Medical Membrane Market might be delayed because of approvals
Manufacturers of pharmaceuticals, biologics, and beverages in the food business are subject to intense international rivalry, which drives them to develop novel pharmaceuticals and biologics that expand the use of medical membrane technologies.
